Postmenopausal tamoxifen treatment and endometrial pathology

Ilan Cohen; Marco M. Altaras; Jeremiah Shapira; Ronnie Tepper; Yoram Beyth

doi:10.1097/00006254-199412000-00006

Postmenopausal tamoxifen treatment and endometrial pathology

Ilan Cohen^*, Marco M. Altaras, Jeremiah Shapira, Ronnie Tepper, Yoram Beyth

^*Corresponding author for this work

Meir Hospital Sapir Medical Center

Research output: Contribution to journal › Review article › peer-review

35 Scopus citations

Abstract

Tamoxifen is widely used as adjuvant therapy for postmenopausal breast cancer patients with positive estrogen receptors. Data on a possible association of endometrial pathologies with tamoxifen treatment have been accumulating. In this review, we examine the current literature and include our own experience with this occurrence. We recommend close supervision of these patients.

Original language	English
Pages (from-to)	823-829
Number of pages	7
Journal	Obstetrical and Gynecological Survey
Volume	49
Issue number	12
DOIs	https://doi.org/10.1097/00006254-199412000-00006
State	Published - Dec 1994

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1097/00006254-199412000-00006

Cite this

@article{59c6c9fae2d94c929567e7f8db5836c2,

title = "Postmenopausal tamoxifen treatment and endometrial pathology",

abstract = "Tamoxifen is widely used as adjuvant therapy for postmenopausal breast cancer patients with positive estrogen receptors. Data on a possible association of endometrial pathologies with tamoxifen treatment have been accumulating. In this review, we examine the current literature and include our own experience with this occurrence. We recommend close supervision of these patients.",

author = "Ilan Cohen and Altaras, {Marco M.} and Jeremiah Shapira and Ronnie Tepper and Yoram Beyth",

year = "1994",

month = dec,

doi = "10.1097/00006254-199412000-00006",

language = "אנגלית",

volume = "49",

pages = "823--829",

journal = "Obstetrical and Gynecological Survey",

issn = "0029-7828",

publisher = "Lippincott Williams and Wilkins Ltd.",

number = "12",

}

TY - JOUR

T1 - Postmenopausal tamoxifen treatment and endometrial pathology

AU - Cohen, Ilan

AU - Altaras, Marco M.

AU - Shapira, Jeremiah

AU - Tepper, Ronnie

AU - Beyth, Yoram

PY - 1994/12

Y1 - 1994/12

N2 - Tamoxifen is widely used as adjuvant therapy for postmenopausal breast cancer patients with positive estrogen receptors. Data on a possible association of endometrial pathologies with tamoxifen treatment have been accumulating. In this review, we examine the current literature and include our own experience with this occurrence. We recommend close supervision of these patients.

AB - Tamoxifen is widely used as adjuvant therapy for postmenopausal breast cancer patients with positive estrogen receptors. Data on a possible association of endometrial pathologies with tamoxifen treatment have been accumulating. In this review, we examine the current literature and include our own experience with this occurrence. We recommend close supervision of these patients.

UR - http://www.scopus.com/inward/record.url?scp=0028034002&partnerID=8YFLogxK

U2 - 10.1097/00006254-199412000-00006

DO - 10.1097/00006254-199412000-00006

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???

AN - SCOPUS:0028034002

SN - 0029-7828

VL - 49

SP - 823

EP - 829

JO - Obstetrical and Gynecological Survey

JF - Obstetrical and Gynecological Survey

IS - 12

ER -

Postmenopausal tamoxifen treatment and endometrial pathology

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this